Functional recovery after neuromuscular blockade in mechanically ventilated critically ill patients

Heart and Lung: Journal of Acute and Critical Care

Volumn 35, Issue 3, 2006, Pages 178-189

  Whetstone Foster, Janet G ^a   Clark, Angela P ^b  

^a TEXAS WOMAN'S UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ATRACURIUM; CALCIUM; CISATRACURIUM; CLINDAMYCIN; CYCLOSPORIN; DILTIAZEM; ESMOLOL; FENTANYL; FUROSEMIDE; GENTAMICIN; GLYCERYL TRINITRATE; HALOPERIDOL; LABETALOL; LORAZEPAM; MAGNESIUM; MANNITOL; METOPROLOL; MIDAZOLAM; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; NICARDIPINE; PANCURONIUM; PENTOBARBITAL; PROPOFOL; ROCURONIUM; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN; VECURONIUM;

ACTIMETRY; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CRITICAL ILLNESS; DESCRIPTIVE RESEARCH; EXTUBATION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; KIDNEY FUNCTION; MALE; METHODOLOGY; MUSCLE CONTRACTION; MUSCLE FUNCTION; MUSCLE WEAKNESS; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR TRANSMISSION; PARALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; VENTILATED PATIENT;

ADULT; AGED; AGED, 80 AND OVER; DRUG SYNERGISM; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR JUNCTION DISEASES; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; RESPIRATION, ARTIFICIAL;

EID: 33646392451     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2005.08.003     Document Type: Article

References (30)

1. Murray M., Cowen J., DeBlock H., Erstad B., Gray A., Tescher A., et al. Clinical guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 30 (2002) 142-156
2. MacFarlane I.A., and Rosenthal F.D. Severe myopathy after status asthmaticus. Lancet 2 (1977) 615
3. Hoyt J.W. Persistent paralysis in the intensive care unit. A clinical conundrum. Crit Care Med 2 (1994) 1
4. Rudis M., Angus E., Peterson E., Popovich J., Hyzy R., and Zarowitz B. Vecuronium (V) dosing by peripheral nerve stimulation (PNS) reduces paralytic dosing requirements and recovery times in critically ill medical patients. a prospective, randomized controlled evaluation. Crit Care Med 24 1 Suppl (1996) A71
5. Douglass J., Tuxen M., and Horne C. Acute myopathy following treatment of severe life threatening asthma. Am Rev Respir Dis 141 (1990) A397
6. Hanschen-Flaschen J., Cowen J., and Raps E. Neuromuscular blockade in the intensive care unit more than we bargained for. Am Rev Respir Dis 147 (1993) 234-236
7. Latronic N., Fenzi F., and Recupero D. Critical illness myopathy and neuropathy. Lancet 347 (1996) 1579-1582
8. Bowman W.C. Physiology and pharmacology of neuromuscular blocking transmission, with special reference to the possible consequences of prolonged blockade. Intensive Care Med 19 (1993) S45-S53
9. Zochdne D.W., Ramsay D., and Shelley S. Acute necrotizing myopathy of intensive care. electrophysiological studies. Muscle Nerve 17 (1994) 285-292
10. Ghez C. The control of movement. In: Kandel E.R., Schwartz J.H., and Jessel T.M. (Eds). Principles of neural science. 4th edition (2000), McGraw-Hill, Health Professions Division, New York 533-547
11. Wagner B.K.J., and O'Hara D.A. Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of critically ill patients. Clin Pharmacokinet 33 (1997) 426-453
12. Silverman D.G., and Standaert F.G. Mechanisms of neuromuscular block. In: Standaert D.G. (Ed). Neuromuscular block in perioperative and intensive care (1994), JB Lippincott, Philadelphia 11-22
13. Foster J., Kish S., and Keenan C. A national survey of critical care nurses' practices related to administration of neuromuscular blocking agents. Am J Crit Care 10 (2001) 139-145
14. Gan T.J., Madan R., and Alexander R. Duration of action of vecuronium after intubating dose of rapacuronium, vecuronium, or succinylcholine. Anesth Analg 92 5 (2001) 1199-1202
15. Caldwell J.E., Szenohradszky J., and Segredo V. The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG7268) and its parent compound vecuronium in human volunteers. J Pharmacol Exp Ther 270 3 (1994) 1216-1222
16. Buck M.L., and Reed M.D. Use of nondepolarizing agents in mechanically ventilated patients. Clin Pharmacol 10 (1991) 32-48
17. Leatherman J.W., Fluegel W.C., David W.S., Davies S.F., and Iber C. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Care Med 153 (1996) 1686-1690
18. Torda T. The nature of gentamicin-induced neuromuscular block. Br J Anesth 52 (1980) 325-328
19. Viby-Mogensen J. Interaction of other drugs with muscle relaxants. Semin Anesth 4 (1985) 52-64
20. Segredo V., Caldwell J.E., Matthay M.A., Sharma M.L., and Gruenke L.D. Pharmacokinetics of vecuronium after long-term administration. (abstract). Anesth Analg 70 (1990) S1-S450
21. Silverman D.G., and Mirakhur R.K. Effects of patient status and condition on nondepolarizing relaxants. In: Standaert D.G. (Ed). Neuromuscular block in perioperative and intensive care (1994), JB Lippincott, Philadelphia 11-22
22. Gooch J.L., Suchyta M.P., Balbierz J.M., Petajan J.H., and Clemmer T.P. Prolonged paralysis after treatment with neuromuscular blocking agents. Crit Care Med 19 9 (1991) 1125-1131
23. Kakulas B.A., and Mastaglia F.L. Drug-induced, toxic and nutritional myopathies. In: Mastaglia F.L., and Detchant L.W. (Eds). Skeletal muscle pathology (1992), Churchill Livingstone, Edinburgh 511-540
24. Medical Research Council. Aids to the examination of the peripheral nervous system (1976), Her Majesty's Stationary Office, London
25. Tryon W.W. Activity measurement in psychology and medicine (1991), Plenum Press, New York
26. Patterson S.M., Krantz D.S., Montgomery L.C., Deuster P.A., Hedges S.M., and Nebel L.E. Automated physical activity monitoring. validation and comparison with physiological and self-report measures. Psychopathology 30 (1993) 296-305
27. Statistical Package for the Social Sciences. SPSS base 10.0 applications guide (1999), SPSS, Inc, Chicago
28. Bercker S., Weber-Carstens S., Deja M., et al. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 33 4 (2005) 711-715
29. Jacobi J., Fraser G.L., Coursin D.B., et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 30 (2002) 119-140
30. Kowalski S.D., and Rayfield C.A. A post hoc descriptive study of patients receiving propofol. Am J Crit Care 8 (1999) 507-513